These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34961444)

  • 1. Blink Rate Study in Patients with Alzheimer's Disease, Mild Cognitive Impairment and Subjective Cognitive Decline.
    D'Antonio F; Bartolo MI; Ferrazzano G; Monti MS; Imbriano L; Trebbastoni A; Berardelli A; Conte A
    Curr Alzheimer Res; 2021; 18(14):1104-1110. PubMed ID: 34961444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From Subjective Cognitive Decline to Alzheimer's Disease: The Predictive Role of Neuropsychological Assessment, Personality Traits, and Cognitive Reserve. A 7-Year Follow-Up Study.
    Bessi V; Mazzeo S; Padiglioni S; Piccini C; Nacmias B; Sorbi S; Bracco L
    J Alzheimers Dis; 2018; 63(4):1523-1535. PubMed ID: 29782316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PER2 C111G polymorphism, cognitive reserve and cognition in subjective cognitive decline and mild cognitive impairment: a 10-year follow-up study.
    Bessi V; Giacomucci G; Mazzeo S; Bagnoli S; Padiglioni S; Balestrini J; Tomaiuolo G; Piaceri I; Carraro M; Bracco L; Sorbi S; Nacmias B
    Eur J Neurol; 2021 Jan; 28(1):56-65. PubMed ID: 32896064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homocysteine - A predictor for five year-mortality in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia.
    Futschek IE; Schernhammer E; Haslacher H; Stögmann E; Lehrner J
    Exp Gerontol; 2023 Feb; 172():112045. PubMed ID: 36509298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olfactory Dysfunction Is Already Present with Subjective Cognitive Decline and Deepens with Disease Severity in the Alzheimer's Disease Spectrum.
    Wang Q; Chen B; Zhong X; Zhou H; Zhang M; Mai N; Wu Z; Huang X; Haehner A; Chen X; Auber LA; Peng Q; Hummel T; Ning Y
    J Alzheimers Dis; 2021; 79(2):585-595. PubMed ID: 33361601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disentangling empathy impairment along Alzheimer's disease continuum: From subjective cognitive decline to Alzheimer's dementia.
    Giacomucci G; Moschini V; Piazzesi D; Padiglioni S; Caruso C; Nuti C; Munarin A; Mazzeo S; Galdo G; Polito C; Emiliani F; Frigerio D; Morinelli C; Bagnoli S; Ingannato A; Nacmias B; Sorbi S; Berti V; Bessi V
    Cortex; 2024 Mar; 172():125-140. PubMed ID: 38301390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
    Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
    Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial Effects of Brain Reserve on Cognition in Individuals with Subjective Cognitive Decline from the SILCODE Study.
    Chen G; Liu C; Yang K; Li Y; Sheng C; Xie Y; Hu X; Jiang J; Han Y
    J Alzheimers Dis; 2020; 75(4):1203-1210. PubMed ID: 32417777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of hippocampal grading as a biomarker for preclinical and prodromal Alzheimer's disease.
    Morrison C; Dadar M; Shafiee N; Collins DL;
    Hum Brain Mapp; 2023 Jun; 44(8):3147-3157. PubMed ID: 36939138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Face-Name Associative Recognition Deficits in Subjective Cognitive Decline and Mild Cognitive Impairment.
    Polcher A; Frommann I; Koppara A; Wolfsgruber S; Jessen F; Wagner M
    J Alzheimers Dis; 2017; 56(3):1185-1196. PubMed ID: 28106560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.
    Yoon JH; Kim M; Moon SY; Yong SW; Hong JM
    J Neurol Sci; 2015 Aug; 355(1-2):174-9. PubMed ID: 26076880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subjective Spatial Navigation Complaints - A Frequent Symptom Reported by Patients with Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer's Disease.
    Cerman J; Andel R; Laczo J; Vyhnalek M; Nedelska Z; Mokrisova I; Sheardova K; Hort J
    Curr Alzheimer Res; 2018; 15(3):219-228. PubMed ID: 29165083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of odor identification among amnestic and non-amnestic mild cognitive impairment, subjective cognitive decline, and early Alzheimer's dementia.
    Park SJ; Lee JE; Lee KS; Kim JS
    Neurol Sci; 2018 Mar; 39(3):557-564. PubMed ID: 29383614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self- and informant-reported cognitive functioning and awareness in subjective cognitive decline, mild cognitive impairment, and very mild Alzheimer disease.
    Ryu SY; Kim A; Kim S; Park KW; Park KH; Youn YC; Lee DW; Lee JY; Lee JH; Jeong JH; Choi SH; Han HJ; Kim S; Na S; Park M; Yim HW; Yang DW
    Int J Geriatr Psychiatry; 2020 Jan; 35(1):91-98. PubMed ID: 31650618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activities of Daily Living and Depressive Symptoms in Patients with Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Stogmann E; Moser D; Klug S; Gleiss A; Auff E; Dal-Bianco P; Pusswald G; Lehrner J
    J Alzheimers Dis; 2016; 49(4):1043-50. PubMed ID: 26577522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
    J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-Administered Gerocognitive Examination: longitudinal cohort testing for the early detection of dementia conversion.
    Scharre DW; Chang SI; Nagaraja HN; Wheeler NC; Kataki M
    Alzheimers Res Ther; 2021 Dec; 13(1):192. PubMed ID: 34872596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal Fluid Biomarkers and Clinical Progression in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment.
    Wolfsgruber S; Polcher A; Koppara A; Kleineidam L; Frölich L; Peters O; Hüll M; Rüther E; Wiltfang J; Maier W; Kornhuber J; Lewczuk P; Jessen F; Wagner M
    J Alzheimers Dis; 2017; 58(3):939-950. PubMed ID: 28527210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A network approach to subjective cognitive decline: Exploring multivariate relationships in neuropsychological test performance across Alzheimer's disease risk states.
    Grunden N; Phillips NA; ;
    Cortex; 2024 Apr; 173():313-332. PubMed ID: 38458017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which features of subjective cognitive decline are related to amyloid pathology? Findings from the DELCODE study.
    Miebach L; Wolfsgruber S; Polcher A; Peters O; Menne F; Luther K; Incesoy E; Priller J; Spruth E; Altenstein S; Buerger K; Catak C; Janowitz D; Perneczky R; Utecht J; Laske C; Buchmann M; Schneider A; Fliessbach K; Kalbhen P; Heneka MT; Brosseron F; Spottke A; Roy N; Teipel SJ; Kilimann I; Wiltfang J; Bartels C; Düzel E; Dobisch L; Metzger C; Meiberth D; Ramirez A; Jessen F; Wagner M
    Alzheimers Res Ther; 2019 Jul; 11(1):66. PubMed ID: 31366409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.